Late Metabolic Effects Common in Testicular Cancer Survivors Late Metabolic Effects Common in Testicular Cancer Survivors
Testicular cancer survivors treated with platinum-based chemotherapy face a 20% risk of developing metabolic syndrome.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Health | Hematology | Metabolic Syndrome | Testicular Cancer